GSK plc
GSK
#228
Rank
HK$750.79 B
Marketcap
HK$374.56
Share price
-0.13%
Change (1 day)
4.36%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): HK$22.54

According to GSK plc's latest financial reports the company's current EPS (TTM) is HK$22.57. In 2025 the company made an earnings per share (EPS) of HK$29.55 an increase over its 2024 EPS that were of HK$12.50.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$22.54-23.73%
2025HK$29.55136.36%
2024HK$12.50-47.35%
2023HK$23.75-64.2%
2022HK$66.33182.29%
2021HK$23.50-18.07%
2020HK$28.6822.34%
2019HK$23.4523.9%
2018HK$18.92140.61%
2017HK$7.8664.45%
2016HK$4.78-90.61%
2015HK$50.91178.12%
2014HK$18.31-48.11%
2013HK$35.2822.68%
2012HK$28.76-11.31%
2011HK$32.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.17 82.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-75.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.53-31.17%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$7.79-65.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.84 147.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$3.53-84.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
-HK$2.51-111.12%๐Ÿ‡บ๐Ÿ‡ธ USA